SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

29 Jul 2025 Evaluate
A fair growth of 11.84% in the revenue at Rs. 595.00 millions was reported in the June 2025 quarter as compared to Rs. 532.00 millions during year-ago period.A slender decline of -6.82% was recorded to Rs. 41.00  millions from Rs. 44.00 millions in the corresponding previous quarter.OP of the company witnessed a marginal growth to 110.00 millions from 101.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 595.00 532.00 11.84 595.00 532.00 11.84 7457.00 7847.00 -4.97
Other Income 7.00 3.00 133.33 7.00 3.00 133.33 996.00 1034.00 -3.68
PBIDT 110.00 101.00 8.91 110.00 101.00 8.91 1317.00 1199.00 9.84
Interest 30.00 33.00 -9.09 30.00 33.00 -9.09 298.00 299.00 -0.33
PBDT 80.00 68.00 17.65 80.00 68.00 17.65 907.00 900.00 0.78
Depreciation 15.00 19.00 -21.05 15.00 19.00 -21.05 531.00 483.00 9.94
PBT 65.00 49.00 32.65 65.00 49.00 32.65 376.00 417.00 -9.83
TAX 24.00 5.00 380.00 24.00 5.00 380.00 184.00 101.00 82.18
Deferred Tax 12.00 5.00 140.00 12.00 5.00 140.00 -14.00 33.00 -142.42
PAT 41.00 44.00 -6.82 41.00 44.00 -6.82 192.00 316.00 -39.24
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.00 159.00 0.00
PBIDTM(%) 18.49 18.98 -2.62 18.49 18.98 -2.62 17.66 15.28 15.59

Jubilant Pharmova Share Price

906.90 -4.70 (-0.52%)
20-Apr-2026 14:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.85
Dr. Reddys Lab 1236.40
Cipla 1233.10
Zydus Lifesciences 937.40
Lupin 2329.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×